Overmolded access port including anchoring and identification features

• US 10,155,101 B2
• Filed: 07/26/2017
• Issued: 12/18/2018
• Est. Priority Date: 11/17/2009
• Status: Active Grant

• Current Assignee: Bard Peripheral Vascular Incorporated (Becton, Dickinson & Co)
• Original Assignee: Bard Peripheral Vascular Incorporated (Becton, Dickinson & Co)
• Inventors: Wiley, Martha R., Noyce, Jodie L., Cise, David M., Barron, William R., Christian, Kelly J., Orome, Amir
• Primary Examiner(s): Bosworth, Kami A
• Application Number:
  US15/660,513
• Publication Number:
  US 20170319842A1
• Time in Patent Office: 510 Days
• CPC Class Codes: A61M 2039/0009 Assemblies therefor designed for particular applications, e.g. contrast or saline injection, suction or irrigation
• CPC Class Codes: A61M 2039/0081 Means for facilitating introduction of a needle in the septum, e.g. guides, special construction of septum
• CPC Class Codes: A61M 2039/0205 for injecting media
• CPC Class Codes: A61M 2039/0223 having means for anchoring the subcutaneous access site
• CPC Class Codes: A61M 2039/0238 having means for locating the implanted device to insure proper injection, e.g. radio-emitter, protuberances, radio-opaque markers
• CPC Class Codes: A61M 39/0208 Subcutaneous access sites for injecting or removing fluids transcutaneous access sites A61M39/0247; implantable infusion devices A61M5/14276
• CPC Class Codes: Y10T 29/49826 Assembling or joining

Abstract

An access port for providing subcutaneous access to a patient is disclosed. In one embodiment, the port includes an internal body defining a fluid cavity that is accessible via a septum. A compliant outer cover including silicone is disposed about at least a portion of the body. A flange is included with the port body and is covered by the outer cover. The flange radially extends about a perimeter of the port body proximate the septum so as to impede penetration of a needle substantially into the outer cover in instances where the needle misses the septum. The flange can further include both an anchoring feature for securing the outer cover to the port body and an identification feature observable via x-ray imaging technology for conveying information indicative of at least one attribute of the access port. The outer cover provides a suitable surface for application of an antimicrobial/antithrombotic coating.

Claims

1. A medical method, comprising:

obtaining a power-injectable access port, comprising;

a body defining a fluid cavity accessible via a septum;

a continuous annular flange circumscribing the septum at a top section of the body proximal of the fluid cavity, the flange formed from a radiopaque material, the flange including one or more identification features that convey to a user that the power-injectable access port is capable of power injection; and

a compliant outer cover disposed about the body and in contact with the flange;

implanting the power-injectable access port in a patient;

connecting a catheter to the power-injectable access port such that a lumen of the catheter is in fluid communication with the fluid cavity; and

identifying the power-injectable access port as capable of power injection by viewing the one or more identification features.

2. The method according to claim 1, wherein the viewing comprises detecting the one or more identification features on an x-ray image following the implanting step.

3. The method according to claim 1, wherein the viewing comprises detecting the one or more identification features visually prior to the implanting step.

4. The method according to claim 1, further comprising accessing the power-injectable access port by inserting a needle transcutaneously through the septum and into the fluid cavity.

5. The method according to claim 4, further comprising injecting contrast media through the power-injectable access port.

6. The method according to claim 5, wherein the injecting step comprises injecting contrast media at a rate of up to five milliliters per second.

7. The method according to claim 4, further comprising aspirating blood through the power-injectable access port.

8. The method according to claim 4, further comprising infusing medicaments through the power-injectable access port.

9. The method according to claim 1, wherein the flange is integrally formed with the body.

10. The method according to claim 9, wherein the flange and the body are formed from a titanium material.

11. The method according to claim 1, wherein the one or more identification features are openings in the flange, the implanting step including threading one or more sutures through the openings to subcutaneously secure the power-injectable access port to the patient.

12. The method according to claim 1, wherein the one or more identification features are openings formed into alphanumeric or symbolic characters.

13. The method according to claim 1, wherein the body is formed from a first material and the flange is formed from a second material different from the first material, and wherein the flange is separate from the body and attached to the body.

14. The method according to claim 13, wherein the flange includes a plurality of keyed notches that each fit over correspondingly keyed tabs on the body, and wherein the tabs are capable of being deformed after the notches are placed over the tabs such that the flange is retained by the body.

15. The method according to claim 14, wherein the body includes acetyl resin, and wherein the flange includes titanium.

16. The method according to claim 1, wherein the flange generally defines a triangular shape including three vertices, and wherein the one or more identification features include alphanumeric indicia disposed at each vertex of the three vertices of the flange.

17. The method according to claim 16, wherein the alphanumeric indicia are defined as recessed features in the flange, and wherein the flange further comprises a plurality of openings defined through the flange.

18. The method according to claim 1, wherein the compliant outer cover includes at least one of an antimicrobial component and an antithrombotic component.

19. The method according to claim 1, wherein the compliant outer cover includes silicone, and wherein at least a portion of a surface of the compliant outer cover is frosted so as to render the portion of the surface substantially opaque.

20. The method according to claim 19, wherein the compliant outer cover includes silicone mixed with a colorant.